activity
20162022
most citedMetaStan: An R package for Bayesian (model-based) meta-analysis using Stan

4 citations · 5 across the 9 of their papers we have counts for

collaborators
Showing 2019Show all

5 papers · 1 filter

stat.AP2019

Present criteria for prophylactic ICD implantation: Insights from the EU-CERT-ICD (Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators in EUrope) project

M. Zabel, S. Schlögl, A. Lubinski +45

BACKGROUND. The clinical effectiveness of primary prevention implantable cardioverter defibrillator (ICD) therapy is under debate. It is urgently needed to better identify patients…

stat.AP2019

Decline of COPD exacerbations in clinical trials over two decades -- a systematic review and meta-regression

Stefan Andreas, Christian Röver, Judith Heinz +3

BACKGROUND: An important goal of chronic obstructive pulmonary disease (COPD) treatment is to reduce the frequency of exacerbations. Some observations suggest a decline in exacerba…

q-bio.QM2019

Random-effects meta-analysis of phase I dose-finding studies using stochastic process priors

Moreno Ursino, Christian Röver, Sarah Zohar +1

Phase I dose-finding studies aim at identifying the maximal tolerated dose (MTD). It is not uncommon that several dose-finding studies are conducted, although often with some varia…

stat.AP2019

Blinded continuous information monitoring of recurrent event endpoints with time trends in clinical trials

Tobias Mütze, Susanna Salem, Norbert Benda +2

Blinded sample size re-estimation and information monitoring based on blinded data has been suggested to mitigate risks due to planning uncertainties regarding nuisance parameters.…

stat.ME20191 cited

Seamless phase II/III clinical trials using early outcomes for treatment or subgroup selection: Methods and aspects of their implementation

Tim Friede, Nigel Stallard, Nicholas Parsons

Adaptive seamless designs combine confirmatory testing, a domain of phase III trials, with features such as treatment or subgroup selection, typically associated with phase II tria…